APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preventive Asthma Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Preventive Asthma Drug Industry Growth and Trends Forecast to 2032

Report ID 174028410119 December 202594 pages

Choose your research edition.

Industry ResearchPreventive Asthma Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Asthma Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Preventive Asthma Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Asthma Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Asthma Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Preventive Asthma Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Preventive Asthma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Preventive Asthma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventive Asthma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preventive Asthma Drug include Callisto Pharmaceuticals, Molecular Insight Pharmaceuticals, Xiaflex, Roche and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Preventive Asthma Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Preventive Asthma Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preventive Asthma Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preventive Asthma Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Preventive Asthma Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Preventive Asthma Drug Market by Company

Callisto Pharmaceuticals

Molecular Insight Pharmaceuticals

Xiaflex

Roche

Novartis AG

Preventive Asthma Drug Segment by Type

Somatostatin Analogs

Chemotherapy

Targeted Therapy

Preventive Asthma Drug Segment by Application

Oncology Centres

Clinics

Hospital

Preventive Asthma Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Asthma Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Asthma Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Asthma Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Preventive Asthma Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Preventive Asthma Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Somatostatin Analogs Table 2. Major Company of Chemotherapy Table 3. Major Company of Targeted Therapy Table 4. Global Preventive Asthma Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Preventive Asthma Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Preventive Asthma Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Preventive Asthma Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Preventive Asthma Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Preventive Asthma Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Preventive Asthma Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Preventive Asthma Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Preventive Asthma Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Preventive Asthma Drug Industry Trends Table 26. Preventive Asthma Drug Industry Drivers Table 27. Preventive Asthma Drug Industry Opportunities and Challenges Table 28. Preventive Asthma Drug Industry Restraints Table 29. Global Preventive Asthma Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Preventive Asthma Drug Revenue Market Share by Company (2021-2026) Table 31. Global Preventive Asthma Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Preventive Asthma Drug Sales Share by Company (2021-2026) Table 33. Global Preventive Asthma Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Preventive Asthma Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Preventive Asthma Drug Major Company Production Sites and Headquarters Table 36. Global Preventive Asthma Drug Company, Product Type & Application Table 37. Global Preventive Asthma Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Preventive Asthma Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Preventive Asthma Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Preventive Asthma Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Preventive Asthma Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Preventive Asthma Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Preventive Asthma Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Preventive Asthma Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Preventive Asthma Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Preventive Asthma Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Preventive Asthma Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Preventive Asthma Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Preventive Asthma Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Preventive Asthma Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Preventive Asthma Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Preventive Asthma Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Preventive Asthma Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Preventive Asthma Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Preventive Asthma Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Preventive Asthma Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Preventive Asthma Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Preventive Asthma Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Callisto Pharmaceuticals Company Information Table 73. Callisto Pharmaceuticals Business Overview Table 74. Callisto Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Callisto Pharmaceuticals Preventive Asthma Drug Product Portfolio Table 76. Callisto Pharmaceuticals Recent Development Table 77. Molecular Insight Pharmaceuticals Company Information Table 78. Molecular Insight Pharmaceuticals Business Overview Table 79. Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Portfolio Table 81. Molecular Insight Pharmaceuticals Recent Development Table 82. Xiaflex Company Information Table 83. Xiaflex Business Overview Table 84. Xiaflex Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Xiaflex Preventive Asthma Drug Product Portfolio Table 86. Xiaflex Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Roche Preventive Asthma Drug Product Portfolio Table 91. Roche Recent Development Table 92. Novartis AG Company Information Table 93. Novartis AG Business Overview Table 94. Novartis AG Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis AG Preventive Asthma Drug Product Portfolio Table 96. Novartis AG Recent Development Table 97. North America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 99. North America Preventive Asthma Drug Sales Market Share by Country (2021-2026) Table 100. North America Preventive Asthma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Preventive Asthma Drug Sales Market Share Forecast by Country (2027-2032) Table 102. North America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Preventive Asthma Drug Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Preventive Asthma Drug Market Share by Country (2021-2026) Table 105. North America Preventive Asthma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Preventive Asthma Drug Market Share Forecast by Country (2027-2032) Table 107. Europe Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 109. Europe Preventive Asthma Drug Sales Market Share by Country (2021-2026) Table 110. Europe Preventive Asthma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Preventive Asthma Drug Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Preventive Asthma Drug Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Preventive Asthma Drug Market Share by Country (2021-2026) Table 115. Europe Preventive Asthma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Preventive Asthma Drug Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Preventive Asthma Drug Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Preventive Asthma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Preventive Asthma Drug Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Preventive Asthma Drug Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Preventive Asthma Drug Market Share by Country (2021-2026) Table 125. Asia-Pacific Preventive Asthma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Preventive Asthma Drug Market Share Forecast by Country (2027-2032) Table 127. Latin America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 129. Latin America Preventive Asthma Drug Sales Market Share by Country (2021-2026) Table 130. Latin America Preventive Asthma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Preventive Asthma Drug Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Preventive Asthma Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Preventive Asthma Drug Market Share by Country (2021-2026) Table 135. Latin America Preventive Asthma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Preventive Asthma Drug Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Preventive Asthma Drug Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Preventive Asthma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Preventive Asthma Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Preventive Asthma Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Preventive Asthma Drug Market Share by Country (2021-2026) Table 145. Middle East and Africa Preventive Asthma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Preventive Asthma Drug Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Preventive Asthma Drug Distributors List Table 150. Preventive Asthma Drug Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Preventive Asthma Drug Image Figure 2. Global Preventive Asthma Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Asthma Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Preventive Asthma Drug Sales (2021-2032) & (K Units) Figure 5. Somatostatin Analogs Image Figure 6. Global Somatostatin Analogs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Chemotherapy Image Figure 8. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Targeted Therapy Image Figure 10. Global Targeted Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Preventive Asthma Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Preventive Asthma Drug Market Share by Type 2025 VS 2032 Figure 13. North America Preventive Asthma Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Preventive Asthma Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Preventive Asthma Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Preventive Asthma Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Preventive Asthma Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Preventive Asthma Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Preventive Asthma Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Preventive Asthma Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Preventive Asthma Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Preventive Asthma Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Preventive Asthma Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Oncology Centres Image Figure 26. Global Oncology Centres Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Preventive Asthma Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Preventive Asthma Drug Market Share by Application 2025 VS 2032 Figure 33. North America Preventive Asthma Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Preventive Asthma Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Preventive Asthma Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Preventive Asthma Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Preventive Asthma Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Preventive Asthma Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Preventive Asthma Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Preventive Asthma Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Preventive Asthma Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Preventive Asthma Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Preventive Asthma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Preventive Asthma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Preventive Asthma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Preventive Asthma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Preventive Asthma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Preventive Asthma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Preventive Asthma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Preventive Asthma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Preventive Asthma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Preventive Asthma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Preventive Asthma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Preventive Asthma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Preventive Asthma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Preventive Asthma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Preventive Asthma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Preventive Asthma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Preventive Asthma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Preventive Asthma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Preventive Asthma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Preventive Asthma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Preventive Asthma Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Preventive Asthma Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Somatostatin Analogs
  • Chemotherapy
  • Targeted Therapy
Applications
  • Oncology Centres
  • Clinics
  • Hospital
Companies covered
  • Callisto Pharmaceuticals
  • Molecular Insight Pharmaceuticals
  • Xiaflex
  • Roche
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Preventive Asthma Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Preventive Asthma Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Preventive Asthma Drug Market by Type
  6. 1.3.1 Somatostatin Analogs
  7. 1.3.2 Chemotherapy
  8. 1.3.3 Targeted Therapy
  9. 1.4 Global Preventive Asthma Drug Market Size by Type
  10. 1.4.1 Global Preventive Asthma Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Preventive Asthma Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Preventive Asthma Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Preventive Asthma Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Preventive Asthma Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Preventive Asthma Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Preventive Asthma Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Preventive Asthma Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Preventive Asthma Drug Industry Trends
  2. 2.2 Preventive Asthma Drug Industry Drivers
  3. 2.3 Preventive Asthma Drug Industry Opportunities and Challenges
  4. 2.4 Preventive Asthma Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Preventive Asthma Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Preventive Asthma Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Preventive Asthma Drug Price (2021-2026)
  4. 3.4 Global Preventive Asthma Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Preventive Asthma Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Preventive Asthma Drug Company, Product Type & Application
  7. 3.7 Global Preventive Asthma Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Preventive Asthma Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Preventive Asthma Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Preventive Asthma Drug Tier 1, Tier 2, and Tier 3
4 Preventive Asthma Drug Regional Status and Outlook
  1. 4.1 Global Preventive Asthma Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Preventive Asthma Drug Historic Market Size by Region
  3. 4.2.1 Global Preventive Asthma Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Preventive Asthma Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Preventive Asthma Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Preventive Asthma Drug Forecasted Market Size by Region
  7. 4.3.1 Global Preventive Asthma Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Preventive Asthma Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Preventive Asthma Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Preventive Asthma Drug by Application
  1. 5.1 Preventive Asthma Drug Market by Application
  2. 5.1.1 Oncology Centres
  3. 5.1.2 Clinics
  4. 5.1.3 Hospital
  5. 5.2 Global Preventive Asthma Drug Market Size by Application
  6. 5.2.1 Global Preventive Asthma Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Preventive Asthma Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Preventive Asthma Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Preventive Asthma Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Preventive Asthma Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Preventive Asthma Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Preventive Asthma Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Preventive Asthma Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Callisto Pharmaceuticals
  2. 6.1.1 Callisto Pharmaceuticals Company Information
  3. 6.1.2 Callisto Pharmaceuticals Business Overview
  4. 6.1.3 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Callisto Pharmaceuticals Preventive Asthma Drug Product Portfolio
  6. 6.1.5 Callisto Pharmaceuticals Recent Developments
  7. 6.2 Molecular Insight Pharmaceuticals
  8. 6.2.1 Molecular Insight Pharmaceuticals Company Information
  9. 6.2.2 Molecular Insight Pharmaceuticals Business Overview
  10. 6.2.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Portfolio
  12. 6.2.5 Molecular Insight Pharmaceuticals Recent Developments
  13. 6.3 Xiaflex
  14. 6.3.1 Xiaflex Company Information
  15. 6.3.2 Xiaflex Business Overview
  16. 6.3.3 Xiaflex Preventive Asthma Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Xiaflex Preventive Asthma Drug Product Portfolio
  18. 6.3.5 Xiaflex Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Preventive Asthma Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Preventive Asthma Drug Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Preventive Asthma Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis AG Preventive Asthma Drug Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America Preventive Asthma Drug Sales by Country
  2. 7.1.1 North America Preventive Asthma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Preventive Asthma Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Preventive Asthma Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Preventive Asthma Drug Market Size by Country
  6. 7.2.1 North America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Preventive Asthma Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Preventive Asthma Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Preventive Asthma Drug Sales by Country
  2. 8.1.1 Europe Preventive Asthma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Preventive Asthma Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Preventive Asthma Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Preventive Asthma Drug Market Size by Country
  6. 8.2.1 Europe Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Preventive Asthma Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Preventive Asthma Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Preventive Asthma Drug Sales by Country
  2. 9.1.1 Asia-Pacific Preventive Asthma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Preventive Asthma Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Preventive Asthma Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Preventive Asthma Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Preventive Asthma Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Preventive Asthma Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Preventive Asthma Drug Sales by Country
  2. 10.1.1 South America Preventive Asthma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Preventive Asthma Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Preventive Asthma Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Preventive Asthma Drug Market Size by Country
  6. 10.2.1 South America Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Preventive Asthma Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Preventive Asthma Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Preventive Asthma Drug Sales by Country
  2. 11.1.1 Middle East and Africa Preventive Asthma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Preventive Asthma Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Preventive Asthma Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Preventive Asthma Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Preventive Asthma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Preventive Asthma Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Preventive Asthma Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Preventive Asthma Drug Value Chain Analysis
  2. 12.1.1 Preventive Asthma Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Preventive Asthma Drug Production Mode & Process
  7. 12.2 Preventive Asthma Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Preventive Asthma Drug Distributors
  10. 12.2.3 Preventive Asthma Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst